Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04079179
Title Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders (NACHO COBI)
Acronym NACHO-COBI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Carl Allen
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.